Pulmonx (LUNG) Receivables (2019 - 2025)
Historic Receivables for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $13.8 million.
- Pulmonx's Receivables rose 1822.62% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 1822.62%. This contributed to the annual value of $13.1 million for FY2024, which is 838.5% up from last year.
- Per Pulmonx's latest filing, its Receivables stood at $13.8 million for Q3 2025, which was up 1822.62% from $15.9 million recorded in Q2 2025.
- Pulmonx's Receivables' 5-year high stood at $15.9 million during Q2 2025, with a 5-year trough of $5.1 million in Q1 2021.
- In the last 5 years, Pulmonx's Receivables had a median value of $8.9 million in 2023 and averaged $9.7 million.
- In the last 5 years, Pulmonx's Receivables soared by 5520.34% in 2021 and then soared by 436.48% in 2022.
- Quarter analysis of 5 years shows Pulmonx's Receivables stood at $6.6 million in 2021, then skyrocketed by 32.23% to $8.7 million in 2022, then surged by 39.51% to $12.1 million in 2023, then increased by 8.38% to $13.1 million in 2024, then rose by 5.16% to $13.8 million in 2025.
- Its last three reported values are $13.8 million in Q3 2025, $15.9 million for Q2 2025, and $14.0 million during Q1 2025.